Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
American Journal of Clinical Pathology|October 20, 2006
Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo diseaseSa A Wang, Naomi Galili, Jan Cerny, et al.International Journal of Hematology|May 10, 2002
Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndromeKrishnan Allampallam, Vilasini Shetty, Suneel Mundle, et al.Journal of Hematology & Oncology|May 2, 2012
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)Azra Raza, Naomi Galili, Deborah Mulford, et al.Leukemia & Lymphoma|June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trialAzra Raza, Joseph G Jurcic, Gail J Roboz, et al.Leukemia Research|August 10, 2010
Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic featuresSa A Wang, Lynne V Abruzzo, Robert P Hasserjian, et al.Blood|February 21, 2013
Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivoJingping Hu, Jing Liu, Fumin Xue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromesRafael Bejar, Kristen E Stevenson, Bennett A Caughey, et al.Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.British Journal of Haematology|February 19, 2002
Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromesPoluru L Reddy, Vilasini T Shetty, Diya Dutt, et al.Journal of Hematology & Oncology|May 15, 2009
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Natalie Callander, et al.Pageof 5